Sumitomo Mitsui DS Asset Management Company Ltd Buys 336 Shares of The Clorox Company (NYSE:CLX)

Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of The Clorox Company (NYSE:CLX) by 2.6% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,193 shares of the company’s stock after purchasing an additional 336 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Clorox were worth $2,143,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in CLX. State Street Corp boosted its position in shares of Clorox by 3.1% in the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC lifted its stake in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the period. Geode Capital Management LLC increased its holdings in Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after buying an additional 33,970 shares during the period. Stifel Financial Corp raised its position in shares of Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after acquiring an additional 37,967 shares in the last quarter. Finally, Van ECK Associates Corp lifted its position in shares of Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after buying an additional 31,510 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

NYSE:CLX opened at $147.08 on Tuesday. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a fifty day simple moving average of $161.06 and a two-hundred day simple moving average of $159.07. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The company has a market cap of $18.21 billion, a price-to-earnings ratio of 40.18, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the business posted $2.16 earnings per share. As a group, equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.32%. Clorox’s dividend payout ratio (DPR) is 133.33%.

Analyst Ratings Changes

CLX has been the topic of a number of recent analyst reports. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Barclays raised their price objective on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Wells Fargo & Company upped their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Finally, DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $158.21.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.